Annual Net Income
$14.85 B
+$7.89 B+113.52%
31 December 2023
Summary:
Novartis AG annual net profit is currently $14.85 billion, with the most recent change of +$7.89 billion (+113.52%) on 31 December 2023. During the last 3 years, it has risen by +$6.78 billion (+83.97%). NVS annual net income is now -38.18% below its all-time high of $24.02 billion, reached on 31 December 2021.NVS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$3.19 B
-$57.00 M-1.76%
30 September 2024
Summary:
Novartis AG quarterly net profit is currently $3.19 billion, with the most recent change of -$57.00 million (-1.76%) on 30 September 2024. Over the past year, it has increased by +$1.43 billion (+81.09%). NVS quarterly net income is now -80.45% below its all-time high of $16.31 billion, reached on 31 December 2021.NVS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$17.60 B
+$1.43 B+8.83%
30 September 2024
Summary:
Novartis AG TTM net profit is currently $17.60 billion, with the most recent change of +$1.43 billion (+8.83%) on 30 September 2024. Over the past year, it has increased by +$9.77 billion (+124.64%). NVS TTM net income is now -27.21% below its all-time high of $24.18 billion, reached on 31 March 2022.NVS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.5% | +81.1% | +124.6% |
| 3 y3 years | +84.0% | +15.6% | +79.5% |
| 5 y5 years | +17.8% | +56.2% | +49.1% |
NVS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.2% | +113.5% | -80.5% | +117.5% | -27.2% | +153.1% |
| 5 y | 5 years | -38.2% | +113.5% | -80.5% | +183.5% | -27.2% | +153.1% |
| alltime | all time | -38.2% | +287.1% | -80.5% | +407.0% | -27.2% | +1299.3% |
Novartis AG Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.19 B(-1.8%) | $17.60 B(+8.8%) |
| June 2024 | - | $3.25 B(+20.8%) | $16.18 B(+6.1%) |
| Mar 2024 | - | $2.69 B(-68.3%) | $15.24 B(+2.7%) |
| Dec 2023 | $14.85 B(+113.5%) | $8.48 B(+381.5%) | $14.85 B(+89.5%) |
| Sept 2023 | - | $1.76 B(-24.0%) | $7.84 B(+2.5%) |
| June 2023 | - | $2.32 B(+1.0%) | $7.65 B(+8.9%) |
| Mar 2023 | - | $2.29 B(+56.4%) | $7.03 B(+1.0%) |
| Dec 2022 | $6.96 B(-71.0%) | $1.47 B(-6.8%) | $6.96 B(-68.1%) |
| Sept 2022 | - | $1.57 B(-7.1%) | $21.80 B(-5.2%) |
| June 2022 | - | $1.69 B(-23.8%) | $22.98 B(-5.0%) |
| Mar 2022 | - | $2.22 B(-86.4%) | $24.18 B(+0.7%) |
| Dec 2021 | $24.02 B(+197.6%) | $16.31 B(+491.3%) | $24.02 B(+144.9%) |
| Sept 2021 | - | $2.76 B(-4.8%) | $9.81 B(+9.2%) |
| June 2021 | - | $2.90 B(+40.7%) | $8.98 B(+12.9%) |
| Mar 2021 | - | $2.06 B(-1.7%) | $7.96 B(-1.4%) |
| Dec 2020 | $8.07 B(-31.2%) | $2.09 B(+8.2%) | $8.07 B(+13.6%) |
| Sept 2020 | - | $1.94 B(+3.6%) | $7.10 B(-1.5%) |
| June 2020 | - | $1.87 B(-14.2%) | $7.21 B(-40.6%) |
| Mar 2020 | - | $2.18 B(+93.4%) | $12.14 B(+3.5%) |
| Dec 2019 | $11.73 B(-7.0%) | $1.13 B(-44.9%) | $11.73 B(-0.6%) |
| Sept 2019 | - | $2.04 B(-70.0%) | $11.80 B(+3.7%) |
| June 2019 | - | $6.80 B(+285.0%) | $11.38 B(-7.8%) |
| Mar 2019 | - | $1.77 B(+47.8%) | $12.35 B(-2.1%) |
| Dec 2018 | $12.61 B(+63.7%) | $1.20 B(-26.4%) | $12.61 B(-5.8%) |
| Sept 2018 | - | $1.62 B(-79.1%) | $13.39 B(-3.3%) |
| June 2018 | - | $7.77 B(+283.6%) | $13.85 B(+71.8%) |
| Mar 2018 | - | $2.02 B(+2.5%) | $8.06 B(+4.7%) |
| Dec 2017 | $7.70 B(+14.8%) | $1.98 B(-5.0%) | $7.70 B(+15.2%) |
| Sept 2017 | - | $2.08 B(+5.1%) | $6.68 B(+2.2%) |
| June 2017 | - | $1.98 B(+18.8%) | $6.54 B(+2.8%) |
| Mar 2017 | - | $1.67 B(+74.1%) | $6.37 B(-5.1%) |
| Dec 2016 | $6.71 B(-62.3%) | $957.00 M(-50.7%) | $6.71 B(-1.4%) |
| Sept 2016 | - | $1.94 B(+7.5%) | $6.81 B(+0.8%) |
| June 2016 | - | $1.80 B(-10.3%) | $6.76 B(-0.5%) |
| Mar 2016 | - | $2.01 B(+90.8%) | $6.79 B(-61.8%) |
| Dec 2015 | $17.78 B(+74.2%) | $1.05 B(-44.2%) | $17.78 B(-2.4%) |
| Sept 2015 | - | $1.89 B(+2.8%) | $18.22 B(-6.8%) |
| June 2015 | - | $1.84 B(-85.9%) | $19.55 B(-3.5%) |
| Mar 2015 | - | $13.01 B(+772.2%) | $20.27 B(+98.6%) |
| Dec 2014 | $10.21 B(+11.3%) | $1.49 B(-53.7%) | $10.21 B(-5.0%) |
| Sept 2014 | - | $3.22 B(+26.1%) | $10.75 B(+10.2%) |
| June 2014 | - | $2.56 B(-13.1%) | $9.76 B(+0.4%) |
| Mar 2014 | - | $2.94 B(+44.9%) | $9.72 B(+5.9%) |
| Dec 2013 | $9.18 B(-1.0%) | $2.03 B(-9.1%) | $9.18 B(+0.5%) |
| Sept 2013 | - | $2.23 B(-11.3%) | $9.13 B(-1.7%) |
| June 2013 | - | $2.52 B(+4.9%) | $9.29 B(-1.4%) |
| Mar 2013 | - | $2.40 B(+20.8%) | $9.42 B(+1.6%) |
| Dec 2012 | $9.27 B | $1.99 B(-16.9%) | $9.27 B(+11.9%) |
| Sept 2012 | - | $2.39 B(-9.7%) | $8.29 B(-0.9%) |
| June 2012 | - | $2.65 B(+17.8%) | $8.36 B(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.25 B(+124.3%) | $8.42 B(-5.9%) |
| Dec 2011 | $8.94 B(-8.7%) | $1.00 B(-59.3%) | $8.94 B(-11.5%) |
| Sept 2011 | - | $2.46 B(-8.9%) | $10.11 B(+1.9%) |
| June 2011 | - | $2.70 B(-2.4%) | $9.92 B(+3.0%) |
| Mar 2011 | - | $2.77 B(+27.7%) | $9.63 B(-1.7%) |
| Dec 2010 | $9.79 B(+16.6%) | $2.17 B(-4.7%) | $9.79 B(-1.4%) |
| Sept 2010 | - | $2.27 B(-5.9%) | $9.93 B(+1.8%) |
| June 2010 | - | $2.42 B(-17.6%) | $9.75 B(+4.1%) |
| Mar 2010 | - | $2.93 B(+27.2%) | $9.37 B(+11.6%) |
| Dec 2009 | $8.40 B(+2.5%) | $2.31 B(+9.9%) | $8.40 B(+10.0%) |
| Sept 2009 | - | $2.10 B(+3.1%) | $7.63 B(+0.1%) |
| June 2009 | - | $2.04 B(+3.7%) | $7.63 B(-2.7%) |
| Mar 2009 | - | $1.96 B(+27.5%) | $7.84 B(-4.3%) |
| Dec 2008 | $8.20 B(-31.4%) | $1.54 B(-26.4%) | $8.20 B(+8.4%) |
| Sept 2008 | - | $2.09 B(-7.1%) | $7.56 B(-38.7%) |
| June 2008 | - | $2.25 B(-2.9%) | $12.34 B(+2.0%) |
| Mar 2008 | - | $2.32 B(+156.3%) | $12.09 B(+1.2%) |
| Dec 2007 | $11.95 B(+66.5%) | $904.00 M(-86.8%) | $11.95 B(-5.9%) |
| Sept 2007 | - | $6.87 B(+241.9%) | $12.70 B(+64.9%) |
| June 2007 | - | $2.01 B(-7.4%) | $7.70 B(+4.1%) |
| Mar 2007 | - | $2.17 B(+31.1%) | $7.40 B(+3.1%) |
| Dec 2006 | $7.17 B(+17.0%) | $1.65 B(-11.4%) | $7.17 B(+4.4%) |
| Sept 2006 | - | $1.87 B(+9.4%) | $6.87 B(+3.1%) |
| June 2006 | - | $1.71 B(-12.3%) | $6.66 B(+0.9%) |
| Mar 2006 | - | $1.95 B(+44.2%) | $6.60 B(+7.6%) |
| Dec 2005 | $6.13 B(+14.3%) | $1.35 B(-18.6%) | $6.14 B(+6.5%) |
| Sept 2005 | - | $1.66 B(+0.8%) | $5.76 B(+2.0%) |
| June 2005 | - | $1.65 B(+11.1%) | $5.65 B(+1.7%) |
| Mar 2005 | - | $1.48 B(+51.7%) | $5.55 B(+3.5%) |
| Dec 2004 | $5.37 B(+13.1%) | $976.00 M(-36.9%) | $5.37 B(-2.0%) |
| Sept 2004 | - | $1.55 B(-0.1%) | $5.48 B(+5.2%) |
| June 2004 | - | $1.55 B(+19.8%) | $5.21 B(+4.7%) |
| Mar 2004 | - | $1.29 B(+19.0%) | $4.97 B(+4.8%) |
| Dec 2003 | $4.74 B(+0.4%) | $1.09 B(-14.9%) | $4.74 B(-1.9%) |
| Sept 2003 | - | $1.28 B(-3.0%) | $4.83 B(+3.6%) |
| June 2003 | - | $1.32 B(+23.8%) | $4.67 B(-1.6%) |
| Mar 2003 | - | $1.06 B(-9.8%) | $4.75 B(-0.6%) |
| Dec 2002 | $4.72 B(+23.2%) | $1.18 B(+6.1%) | $4.77 B(+13.0%) |
| Sept 2002 | - | $1.11 B(-20.2%) | $4.22 B(-0.4%) |
| June 2002 | - | $1.39 B(+27.7%) | $4.24 B(+9.1%) |
| Mar 2002 | - | $1.09 B(+73.3%) | $3.89 B(+0.5%) |
| Dec 2001 | $3.84 B(-14.1%) | $629.00 M(-44.2%) | $3.87 B(-12.2%) |
| Sept 2001 | - | $1.13 B(+8.6%) | $4.40 B(+6.1%) |
| June 2001 | - | $1.04 B(-3.0%) | $4.15 B(-5.5%) |
| Mar 2001 | - | $1.07 B(-8.0%) | $4.39 B(-4.1%) |
| Dec 2000 | $4.47 B(+6.8%) | $1.16 B(+32.9%) | $4.58 B(+34.1%) |
| Sept 2000 | - | $876.00 M(-31.7%) | $3.42 B(+34.5%) |
| June 2000 | - | $1.28 B(+1.9%) | $2.54 B(+101.9%) |
| Mar 2000 | - | $1.26 B | $1.26 B |
| Dec 1999 | $4.18 B(-4.3%) | - | - |
| Dec 1998 | $4.37 B | - | - |
FAQ
- What is Novartis AG annual net profit?
- What is the all time high annual net income for Novartis AG?
- What is Novartis AG annual net income year-on-year change?
- What is Novartis AG quarterly net profit?
- What is the all time high quarterly net income for Novartis AG?
- What is Novartis AG quarterly net income year-on-year change?
- What is Novartis AG TTM net profit?
- What is the all time high TTM net income for Novartis AG?
- What is Novartis AG TTM net income year-on-year change?
What is Novartis AG annual net profit?
The current annual net income of NVS is $14.85 B
What is the all time high annual net income for Novartis AG?
Novartis AG all-time high annual net profit is $24.02 B
What is Novartis AG annual net income year-on-year change?
Over the past year, NVS annual net profit has changed by +$7.89 B (+113.52%)
What is Novartis AG quarterly net profit?
The current quarterly net income of NVS is $3.19 B
What is the all time high quarterly net income for Novartis AG?
Novartis AG all-time high quarterly net profit is $16.31 B
What is Novartis AG quarterly net income year-on-year change?
Over the past year, NVS quarterly net profit has changed by +$1.43 B (+81.09%)
What is Novartis AG TTM net profit?
The current TTM net income of NVS is $17.60 B
What is the all time high TTM net income for Novartis AG?
Novartis AG all-time high TTM net profit is $24.18 B
What is Novartis AG TTM net income year-on-year change?
Over the past year, NVS TTM net profit has changed by +$9.77 B (+124.64%)